Researchers from King Abdullah University of Science and Technology (KAUST) have developed deepBlastoid, the first deep-learning platform specifically designed for the high-throughput, automated classification of human stem cell-derived embryo models (blastoids). By leveraging a ResNet-18 architecture and a novel Confidence Rate metric, the model achieves up to 97% accuracy and processes images 1,000 times faster than human experts. This tool facilitates large-scale drug screening and basic research into early human development by providing a standardized, objective evaluation framework.

Cancer research is undergoing a profound transformation. Advances in molecular and cellular biology, genomics, immunology, engineering, and computational science have reshaped our understanding of cancer as a complex, multiscale disease. Yet the gap between biological discovery and durable clinical benefit remains a central challenge. Addressing this gap increasingly requires integration across disciplines, technologies, and conceptual frameworks. Advanced Cancer Research is an international, peer-reviewed, open-access journal publishing original cancer research spanning basic, translational, and clinical investigation. The journal prioritizes studies that provide mechanistic depth, introduce conceptual or technological innovation, or offer system-level insight into cancer biology and therapy, with particular emphasis on work that bridges disciplinary boundaries and advances translational relevance.

Opioid overdoses continue to take a devastating toll across the United States. According to the U.S. Centers for Disease Control and Prevention (CDC), in 2023, the nation recorded roughly 105,000 drug overdose deaths overall, with nearly 80,000 deaths involving opioids. Worldwide, opioids are also responsible for the majority of drug-related deaths. A University of California San Diego study is working on a potentially life-saving measure that may be as simple as strapping on a smartwatch.